Correlation Between Orascom Construction and Memphis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Orascom Construction and Memphis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orascom Construction and Memphis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Orascom Construction PLC and Memphis Pharmaceuticals, you can compare the effects of market volatilities on Orascom Construction and Memphis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orascom Construction with a short position of Memphis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orascom Construction and Memphis Pharmaceuticals.

Diversification Opportunities for Orascom Construction and Memphis Pharmaceuticals

0.0

Correlation Coefficient

Orascom Construction  Memphis Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Orascom and Memphis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Orascom Construction PLC and Memphis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memphis Pharmaceuticals and Orascom Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orascom Construction PLC are associated (or correlated) with Memphis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memphis Pharmaceuticals has no effect on the direction of Orascom Construction i.e., Orascom Construction and Memphis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Orascom Construction and Memphis Pharmaceuticals

Assuming the 90 days trading horizon Orascom Construction is expected to generate 12.58 times less return on investment than Memphis Pharmaceuticals. But when comparing it to its historical volatility, Orascom Construction PLC is 3.17 times less risky than Memphis Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Memphis Pharmaceuticals is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  5,257  in Memphis Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  2,820  from holding Memphis Pharmaceuticals or generate 53.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Orascom Construction PLC  vs.  Memphis Pharmaceuticals

Orascom Construction PLC

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Orascom Construction PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Orascom Construction is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Memphis Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Orascom Construction and Memphis Pharmaceuticals

The main advantage of trading using opposite Orascom Construction and Memphis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orascom Construction position performs unexpectedly, Memphis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memphis Pharmaceuticals will offset losses from the drop in Memphis Pharmaceuticals' long position.

The idea behind Orascom Construction PLC and Memphis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.